Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung

Lung Cancer

Volumn 30, Issue 2, 2000, Pages 73-81

  Hosomi, Yukio ^a,b   Yokose, Tomoyuki ^a   Hirose, Yuko ^a   Nakajima, Ryu ^a,b   Nagai, Kanji ^b   Nishiwaki, Yutaka ^b   Ochiai, Atsushi ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

Adenocarcinoma; Atypical adenomatous hyperplasia; Carcinogenesis; Chemoprevention; Cyclooxygenase 2; Lung cancer

Indexed keywords

CYCLOOXYGENASE 2;

ADENOMA; ADULT; AGED; ARTICLE; CANCER INVASION; CATALYSIS; CELL TRANSFORMATION; DRUG BLOOD LEVEL; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; AGED; CYCLOOXYGENASE 2; FEMALE; HUMANS; HYPERPLASIA; ISOENZYMES; LUNG; LUNG NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROGNOSIS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TUMOR MARKERS, BIOLOGICAL;

EID: 0033735989     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(00)00132-X     Document Type: Article

References (42)

1. Identification of a phorbol ester-repressible v-src-inducible gene
2. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue
3. Prostaglandin endoperoxide synthase: Why two isoforms?
4. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells
5. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
6. Expression of cyclooxygenase-1 and -2 in human colorectal cancer
7. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas
8. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas
9. Expression of cyclooxygenase-2 in human lung carcinoma
10. Cyclooxygenase-2 expression in human esophageal carcinoma
11. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer
12. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck
13. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
14. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis
15. Aspirin use and reduced risk of fatal colon cancer
16. Aspirin use and lung, colon, and breast cancer incidence in a prospective study
17. Aspirin and the risk of colorectal cancer in women
18. Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas
19. Non-small cell lung cancer cycloxygenase activity and proliferation are inhibited by non-steroidal anti-inflammatory drugs
20. Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: Up-regulation of interleukin 10 and down-regulation of interleukin 12 production
21. The spectrum and significance of bronchioloalveolar carcinomas
22. Alveolar atypical hyperplasia in association with primary pulmonary adenocarcinoma: A clinicopathological study of 10 cases
23. Precursors to pulmonary neoplasia
24. Atypical adenomatous hyperplasia and adenocarcinoma of the human lung: Their heterology in form and analogy in immunohistochemical characteristics
25. Clonal growth of atypical adenomatous hyperplasia of the lung: Cytofluorometric analysis of nuclear DNA content
26. Differentiation of atypical adenomatous hyperplasia and adenocarcinoma of the lung by use of DNA ploidy and morphometric analysis
27. Monoclonality of atypical adenomatous hyperplasia of the lung
28. Atypical alveolar hyperplasia: Relationship with pulmonary adenocarcinoma, p53, and c-erbB-2 expression
29. Proliferative potential and p53 overexpression in precursor and early stage lesions of bronchioloalveolar lung carcinoma
30. Bronchioloalveolar carcinoma: Focal area of ground-glass attenuation at thin-section CT as an early sign
31. Multiple atypical adenomatous hyperplasia of type II pneumonocytes and bronchiolo-alveolar carcinoma
32. Bronchioloalveolar cell adenomas
33. The prognosis of resected lung carcinoma associated with atypical adenomatous hyperplasia: A comparison of the prognosis of well-differentiated adenocarcinoma associated with atypical adenomatous hyperplasia and intrapulmonary metastasis
34. Surgically curable 'early' adenocarcinoma in the periphery of the lung
35. Prognostic implications of fibrotic focus (scar) in small peripheral lung cancers
36. Recovery from 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced immunosuppression in A/J mice by treatment with nonsteroidal anti-inflammatory drugs
37. Prevention of NNK-induced lung tumorigenesis in A/J mice by acetylsalicylic acid and NS-398
38. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
39. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
40. Cyclooxygenase regulates angiogenesis induced by colon cancer cells
41. Chronic infections and inflammatory processes as cancer risk factors: Possible role of nitric oxide in carcinogenesis